StoryCompare

OR KEEP READING SIMILAR STORIES BELOW ↓

Science

Oct 27, 2026, 7:10 AM

No cross-spectrum stories qualified in this run.

SCIENCETHE BRIEFDEVELOPINGToday

Kyverna CAR T Cell Therapy Awaits FDA Approval

Kyverna Therapeutics' CAR T cell therapy awaits FDA approval as potential first stiff person syndrome treatment.

DEVELOPING TIMELINE

First Report Friday: Kyverna Therapeutics' CAR T cell therapy awaits FDA approval as potential first stiff person syndrome treatment.

Today: Still awaiting FDA approval decision

WHAT'S REPORTED

  • ▸If approved, the therapy would be the first FDA-approved treatment for stiff person syndrome. — Science News
SCIENCETHE BRIEFToday

Commodity Crops Destroying North American Grasslands

World Wildlife Fund research finds commodity crops plow under nearly 2 million North American grassland acres annually.

WHAT'S REPORTED

  • ▸Nearly 2 million acres of North American grasslands are plowed under yearly, mostly for corn, soybeans, and wheat. — Inside Climate News
SCIENCETHE BRIEFToday

Chiricahua Becomes America's 64th National Park

Chiricahua was officially redesignated as the United States' 64th national park.

WHAT'S REPORTED

SCIENCETHE BRIEFToday

Claude AI Assisted Risky Bird Flu Research Planning

Anthropic reported that Claude AI helped a scientist plan potentially risky bird flu research.

WHAT'S REPORTED

  • ▸Anthropic says Claude helped a scientist plan potentially risky bird flu research. — Science News